The appointment of Kate Woolland as new Chief Operating Officer of London-based Closed Loop Medicine Ltd supports delivery of the Company’s product and partnership programs.
https://european-biotechnology.com/wp-content/uploads/2024/04/eb.com_Kate_Woolland__COO_kl-scaled.jpg25602278Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-06-21 15:08:392024-07-16 17:01:05Closed Loop Medicine appoints new COO
https://european-biotechnology.com/wp-content/uploads/2024/04/emb223_southern_rechts_mm.jpg720960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-06-21 13:09:372024-06-21 12:51:40First island with zero waste
Inflation has rebounded with a vengeance from its pandemic-induced recession lows. The US headline inflation rate surged to levels not seen since Ronald Reagan’s presidency, while the Eurozone’s Harmonised Index of Consumer Price (HICP) rose to the highest level in its entire 30-year lifespan.
https://european-biotechnology.com/wp-content/uploads/2024/04/EB223_Dirk_Carrez_Intro_kl.jpg11822101Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2023-06-21 00:00:002024-12-03 08:56:46Biotech companies challenged in times of inflation
Santhera Pharmaceuticals Holding has exclusively granted the rights to commercialise its Duchenne muscular dystrophy drug vamorolone in North America to Catalyst Pharmaceuticals Inc.
Swedish personalised immunotherapy specialist Neogap Therapeutics AB has acquired the remaining shares of its subsidiary, TCER Oncology AB through two new shareholders.
An international research team headed by Pablo Guardado-Calvo at Institut Pasteur Paris has demonstrated evaluated antibody efficacy against lethal hantaviruses.
3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing for biological drugs advances its international expansion with the opening of its first commercial office in the United States located in Boston, Massachusetts.
https://european-biotechnology.com/wp-content/uploads/2024/04/Picture_of_Boston_-_financial_district.jpeg637960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-06-13 14:00:482024-07-11 13:25:173P Biopharmaceuticals lands in the United States.
Closed Loop Medicine appoints new COO
AppointmentsThe appointment of Kate Woolland as new Chief Operating Officer of London-based Closed Loop Medicine Ltd supports delivery of the Company’s product and partnership programs.
First island with zero waste
BackgroundTilos marks the first island to achieve 100% diversion from landfill with an 87% recycling rate.
Biotech companies challenged in times of inflation
OpinionInflation has rebounded with a vengeance from its pandemic-induced recession lows. The US headline inflation rate surged to levels not seen since Ronald Reagan’s presidency, while the Eurozone’s Harmonised Index of Consumer Price (HICP) rose to the highest level in its entire 30-year lifespan.
Smarter, faster, cheaper: Veeva shows how
Latest NewsThis year’s Veeva R&D and Quality Summit in Madrid, accentuated the current trends and needs of the pharma and life sciences industries.
Santhera licences vamorolone rights to Catalyst Pharmaceuticals
Latest NewsSanthera Pharmaceuticals Holding has exclusively granted the rights to commercialise its Duchenne muscular dystrophy drug vamorolone in North America to Catalyst Pharmaceuticals Inc.
BioSenic halts ALLOB development
Latest NewsBioSenic SA has suspended its Phase II proof-of-concept trial on fracture healing with its allogeneic cell therapy ALLOB.
Neogap fully takes over TCER Oncology shares
Latest NewsSwedish personalised immunotherapy specialist Neogap Therapeutics AB has acquired the remaining shares of its subsidiary, TCER Oncology AB through two new shareholders.
Antibody provides broad protection vs hantaviruses
Latest NewsAn international research team headed by Pablo Guardado-Calvo at Institut Pasteur Paris has demonstrated evaluated antibody efficacy against lethal hantaviruses.
New headquarter in Krakow
BackgroundThe new Krakow headquarters of preclinical CRO Selvita have opened.
3P Biopharmaceuticals lands in the United States.
Background